GRN1005 for Brain Metastases From Breast or Lung Cancer
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Lung Neoplasms|Breast Neoplasms|Lung Cancer
Interventions: DRUG: Trastuzumab|DRUG: GRN 1005
Sponsor: National Cancer Institute (NCI)